Nutrien Ltd. (NYSE:NTR) Shares Sold by Palouse Capital Management Inc.

Palouse Capital Management Inc. lessened its stake in Nutrien Ltd. (NYSE:NTR) by 0.7% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 53,426 shares of the company’s stock after selling 384 shares during the period. Nutrien comprises 1.6% of Palouse Capital Management Inc.’s investment portfolio, making the stock its 26th biggest position. Palouse Capital Management Inc.’s holdings in Nutrien were worth $2,391,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the business. HHM Wealth Advisors LLC increased its stake in Nutrien by 331.0% during the 4th quarter. HHM Wealth Advisors LLC now owns 625 shares of the company’s stock worth $28,000 after buying an additional 480 shares in the last quarter. Asset Planning Inc acquired a new position in Nutrien in the fourth quarter valued at approximately $35,000. Exchange Traded Concepts LLC lifted its holdings in Nutrien by 96.7% in the fourth quarter. Exchange Traded Concepts LLC now owns 846 shares of the company’s stock valued at $38,000 after acquiring an additional 416 shares during the last quarter. Principal Securities Inc. lifted its stake in Nutrien by 138.1% during the fourth quarter. Principal Securities Inc. now owns 931 shares of the company’s stock worth $42,000 after purchasing an additional 540 shares in the last quarter. Finally, Union Bancaire Privee UBP SA acquired a new position in Nutrien during the fourth quarter worth $67,000. Hedge funds and other institutional investors own 63.10% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on NTR. CIBC reaffirmed an “outperformer” rating and set a $55.00 price objective (down previously from $60.00) on shares of Nutrien in a research report on Tuesday, December 10th. UBS Group increased their target price on shares of Nutrien from $51.00 to $53.00 and gave the stock a “neutral” rating in a research note on Tuesday, January 28th. Wells Fargo & Company increased their target price on shares of Nutrien from $52.00 to $53.00 and gave the stock an “equal weight” rating in a research note on Tuesday, January 28th. Piper Sandler raised their price objective on shares of Nutrien from $58.00 to $63.00 and gave the company an “overweight” rating in a research report on Monday, January 27th. Finally, JPMorgan Chase & Co. raised shares of Nutrien from an “underweight” rating to a “neutral” rating and increased their target price for the company from $40.00 to $50.00 in a report on Monday, January 13th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $59.00.

Nutrien Price Performance

Shares of NTR opened at $50.92 on Friday. The firm has a market capitalization of $25.01 billion, a PE ratio of 34.18, a PEG ratio of 1.13 and a beta of 0.81. The company’s 50-day moving average is $49.02 and its 200-day moving average is $48.14. Nutrien Ltd. has a fifty-two week low of $43.69 and a fifty-two week high of $60.87. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82.

Nutrien Company Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.